SCHEMBL30457465

SCHEMBL30457465

O=C1CC(=O)N(c2cccc(Br)c2)C(=S)N1

nearest known ligand 0.76

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 8/20 0.76
KMT2A Q03164 8/20 0.76
MAPT P10636 6/20 0.52
HSD17B10 Q99714 3/20 0.51
L3MBTL1 Q9Y468 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.49
MGLL Q99685 1/20 0.49
ALOX5 P09917 2/20 0.47
BCL2A1 Q16548 1/20 0.46
ALOX15 P16050 1/20 0.46
ALOX12 P18054 1/20 0.46
HBB P68871 1/20 0.46
ATM Q13315 1/20 0.43
ALDH1A1 P00352 3/20 0.42
GAA P10253 1/20 0.41
HTT P42858 1/20 0.41
RECQL P46063 1/20 0.41
NPC1 O15118 1/20 0.41
P2RX4 Q99571 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25633524 1.00 MEN1 (0.76) MEN1KMT2AMAPTHSD17B10L3MBTL1
SCHEMBL30458052 0.86 MEN1 (1.00) MEN1KMT2AMAPTHSD17B10L3MBTL1
SCHEMBL25633552 0.86 MEN1 (1.00) MEN1KMT2AMAPTHSD17B10L3MBTL1
SCHEMBL30457532 0.82 MAPT (0.56) MEN1KMT2AMAPTHSD17B10L3MBTL1
SCHEMBL25228060 0.81 MAPT (0.79) MEN1KMT2AMAPTHSD17B10L3MBTL1
SCHEMBL123633 0.81 GRK5 (0.56) MEN1KMT2AMAPTHSD17B10L3MBTL1
SCHEMBL25633581 0.80 MEN1 (0.62) MEN1KMT2AMAPTHSD17B10L3MBTL1
SCHEMBL25633527 0.79 MEN1 (0.78) MEN1KMT2AMAPTHSD17B10L3MBTL1
SCHEMBL8114973 0.76 MEN1 (0.66) MEN1KMT2AMAPTHSD17B10L3MBTL1
SCHEMBL9982424 0.73 MEN1 (0.61) MEN1KMT2AP2RX4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250051314-A1 SMALL MOLECULE INHIBITORS OF INTERFERON GAMMA SIGNALING PARIS SCIENCES ET LETTRES (FR) 2025-02-13 US disclosed
EP-4444308-A1 SMALL MOLECULE INHIBITORS OF INTERFERON GAMMA SIGNALING Institut Curie (FR) 2024-10-16 EP disclosed
WO-2023104976-A1 SMALL MOLECULE INHIBITORS OF INTERFERON GAMMA SIGNALING INSTITUT CURIE (FR) 2023-06-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250051314-A1 SMALL MOLECULE INHIBITORS OF INTERFERON GAMMA SIGNALING STAT1, IFNG, IRF2BP2 MEN1 3227/4885KMT2A 2840/4885MAPT 4087/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.